Search Results 81-90 of 14983 for TNF
... TNF-inhibitors. Correlate local levels of antigen with systemic levels measured in serum using matched patient tissue and blood sample, and correlate local ...
Mayo Clinic Researchers: TNF Inhibitors May Increase Cancer Risk in the Eye. Robert Nellis. November 13, 2014. Cancer. Mayo Clinic Researchers Identify First ...
The lab is examining the hypothesis that ductular reactive cells induce macrophage TNF-related apoptosis-inducing ligand (TRAIL) expression as a counter- ...
Hypothesis: Baseline cytokine (IL-1β, IL-6, IL-4, IL-10, IFN-g and TNF-a) and the immune cellular repertoire (helper/CD4+, cytotoxic/CD8+, T-regulatory ...
TNF-related apoptosis-inducing ligand (TRAIL) short, an antagonistic TRAIL splice variant. Casp8p41, a fragment of caspase-8 that is produced through the ...
... tumor necrosis factor (TNF) antagonist (adalimumab subcutaneously [SC]), and an immunomodulator (oral methotrexate) on endoscopic remission in participants ...
The research team discovered that increased activity of the alternative NF-kB pathway results from suppression of TNF receptor-associated factor 2, or TRAF2.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.